According to our new research study on “Pharmaceutical Robots Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product, Application, and End User” the market is expected to reach US$ 159.23 million in 2021 and is projected to reach US$ 383.91 million by 2028; it is expected to grow at a CAGR of 13.4% from 2021 to 2028. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Pharmaceutical industry requires efficient and precise precision in production of pharmaceutical drugs. Thus, using robots in pharmaceutical manufacturing improves quality and reduces cost and time. Robots are proving advantageous in filling, inspection, packaging, laboratories, and the manufacture of personalized medicine. A robotic system is a type of automation that has multiple axes of motion and can be programmed to perform any function.

Get Sample Copy @ https://www.theinsightpartners.com/sample/TIPMD00002342/

Key Players -

ABB Ltd.; Kawasaki Heavy Industries, Ltd.; Yaskawa Electric Corporation; Universal Robots A/S; Marchesini Group S.p.A; Denso Corporation; Fanuc Corporation; Espon India Pvt. Ltd.; Shibuya Corporation; and Weiss GmbH are among the leading companies operating in the pharmaceutical robots market.

The pharmaceutical robots market is characterized by the presence of various small and big companies. The market players are adopting the strategies such as new product launch, geographic expansion, and technological advancements to increase their market share. In May 2019, FANUC CORPORATION is pleased to announce the construction of a new factory for ROBONANO. The existing ROBONANO factories (two buildings) will be combined and shall be replaced by the new factory. The new factory will enhance production of the ROBONANO for turning, which is a new addition to the lineup of the current ROBONANO for machining. Similarly, in October 2020, ABB acquired Codian Robotics B.V., a manufacturer of delta robots, which are used primarily for high-precision pick and place applications. With the transaction, ABB is accelerating its engagement in the growing field of delta robots.

Codian Robotics’ technologies and industry expertise are ideal for the company’s portfolio of food and beverage, pharmaceutical, service robotics and logistics solutions, is a projected to support ABB’s machine-centric robotics offerings. Further, in July 2020, Epson Robots has signed Olympus Controls, an engineering services provider that specializes in the integration of motion control, machine vision, and robotic technologies, as an official distributor of its automation products. For instance, in February 2018, ABB, the manufacturer and supplier of industrial robots; Covariant, an Artificial Intelligence start-up (AI) went into a partnership to bring AI-enabled robotics solutions to market, starting with a fully autonomous warehouse order fulfilment solution.